Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Nicox S.A. (Euronext:COX) said FDA approved an NDA for Zerviate cetirizine (AC-170) to treat
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury